KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Net Margin (2016 - 2025)

Historic Net Margin for Regeneron Pharmaceuticals (REGN) over the last 17 years, with Q4 2025 value amounting to 21.74%.

  • Regeneron Pharmaceuticals' Net Margin fell 24700.0% to 21.74% in Q4 2025 from the same period last year, while for Dec 2025 it was 31.41%, marking a year-over-year increase of 3400.0%. This contributed to the annual value of 31.41% for FY2025, which is 3400.0% up from last year.
  • Regeneron Pharmaceuticals' Net Margin amounted to 21.74% in Q4 2025, which was down 24700.0% from 38.89% recorded in Q3 2025.
  • Regeneron Pharmaceuticals' 5-year Net Margin high stood at 1947.0% for Q1 2022, and its period low was 21.74% during Q4 2025.
  • Moreover, its 5-year median value for Net Margin was 36.95% (2025), whereas its average is 189.22%.
  • Per our database at Business Quant, Regeneron Pharmaceuticals' Net Margin soared by 19029000bps in 2022 and then crashed by -19211400bps in 2023.
  • Over the past 5 years, Regeneron Pharmaceuticals' Net Margin (Quarter) stood at 45.01% in 2021, then soared by 2559bps to 1197.1% in 2022, then plummeted by -97bps to 33.77% in 2023, then fell by -28bps to 24.22% in 2024, then fell by -10bps to 21.74% in 2025.
  • Its Net Margin stands at 21.74% for Q4 2025, versus 38.89% for Q3 2025 and 37.86% for Q2 2025.